ES508609A0 - Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol. - Google Patents

Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.

Info

Publication number
ES508609A0
ES508609A0 ES508609A ES508609A ES508609A0 ES 508609 A0 ES508609 A0 ES 508609A0 ES 508609 A ES508609 A ES 508609A ES 508609 A ES508609 A ES 508609A ES 508609 A0 ES508609 A0 ES 508609A0
Authority
ES
Spain
Prior art keywords
levonantradol
methyl
procedure
preparation
stable aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES508609A
Other languages
English (en)
Other versions
ES8304429A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8304429A1 publication Critical patent/ES8304429A1/es
Publication of ES508609A0 publication Critical patent/ES508609A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES508609A 1981-01-09 1982-01-08 Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol. Granted ES508609A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/223,672 US4406888A (en) 1981-01-09 1981-01-09 Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution

Publications (2)

Publication Number Publication Date
ES8304429A1 ES8304429A1 (es) 1983-03-01
ES508609A0 true ES508609A0 (es) 1983-03-01

Family

ID=22837540

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508609A Granted ES508609A0 (es) 1981-01-09 1982-01-08 Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.

Country Status (17)

Country Link
US (1) US4406888A (es)
EP (1) EP0056681A3 (es)
JP (1) JPS57136512A (es)
AU (1) AU528316B2 (es)
CA (1) CA1172569A (es)
CS (1) CS235524B2 (es)
DK (1) DK4382A (es)
ES (1) ES508609A0 (es)
FI (1) FI813969L (es)
GR (1) GR76514B (es)
HU (1) HU186462B (es)
IL (1) IL64731A0 (es)
NO (1) NO820045L (es)
NZ (1) NZ199415A (es)
PH (1) PH17593A (es)
PT (1) PT74257B (es)
ZA (1) ZA82118B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33239E (en) * 1983-09-06 1990-06-26 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2391552A (en) * 1942-02-25 1945-12-25 Curtis David Stabilized aromatic compounds
BE786427A (fr) * 1971-07-19 1973-01-18 Pfizer Compositions aqueuses de doxycycline
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
HU180917B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
JPS54157818A (en) * 1978-06-02 1979-12-13 Tokyo Tanabe Co Injectionable preparation of chlorethylnitrosourea compound
US4320124A (en) * 1980-10-17 1982-03-16 Pfizer Inc. Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof

Also Published As

Publication number Publication date
PT74257A (en) 1982-02-01
GR76514B (es) 1984-08-10
ZA82118B (en) 1982-11-24
FI813969L (fi) 1982-07-10
ES8304429A1 (es) 1983-03-01
IL64731A0 (en) 1982-03-31
HU186462B (en) 1985-08-28
US4406888A (en) 1983-09-27
EP0056681A3 (en) 1983-07-20
NZ199415A (en) 1985-04-30
AU7940482A (en) 1982-07-22
CA1172569A (en) 1984-08-14
AU528316B2 (en) 1983-04-21
DK4382A (da) 1982-07-10
CS235524B2 (en) 1985-05-15
NO820045L (no) 1982-07-12
EP0056681A2 (en) 1982-07-28
JPS57136512A (en) 1982-08-23
PT74257B (en) 1984-05-29
PH17593A (en) 1984-10-02

Similar Documents

Publication Publication Date Title
ES511339A0 (es) Un procedimiento para la produccion de un agente espesante para sistemas acuosos.
ES512882A0 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES510696A0 (es) Un procedimiento para la preparacion de nuevos tiojenos o furanos.
ES513366A0 (es) Un procedimiento para la preparacion de nuevas n-aril-piperazin alcanamidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES541336A0 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofen.
ES522451A0 (es) Un procedimiento para la preparacion de una urea.
ES504291A0 (es) Un procedimiento para la preparacion de benzotio-en y benzofuransulfonamidas.
ES511123A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES521871A0 (es) Procedimiento para la preparacion de nuevos benzo-heterociclos.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES511124A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES511663A0 (es) Un procedimiento para la preparacion de un heteropoliacido.
ES522446A0 (es) Procedimiento para la preparacion de alfa-halobencil-alfa-(3-piridil o 2-pirizinil)-alcanoles.
ES514311A0 (es) Un procedimiento para la preparacion de benzofurasulfamatos.
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES509312A0 (es) Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES511665A0 (es) Un procedimiento para la preparacion de fenilaminoimidazolidinas.
ES509432A0 (es) Un procedimiento para la preparacion de arilaminas.
ES518136A0 (es) Un procedimiento para la preparacion de eteres alquil-naftilicos.
ES508609A0 (es) Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.
ES512026A0 (es) Un procedimiento para la preparacion de ranitidina.
ES521152A0 (es) Un procedimiento para la preparacion de glutation.
ES517153A0 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.